Susquehanna International Group’s Dare Bioscience DARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $255K | Buy |
106,887
+48,723
| +84% | +$116K | ﹤0.01% | 5248 |
|
|
2025
Q1 | $168K | Buy |
58,164
+17,582
| +43% | +$50.8K | ﹤0.01% | 5610 |
|
|
2024
Q4 | $127K | Buy |
+40,582
| New | +$127K | ﹤0.01% | 5572 |
|
|
2024
Q3 | – | Sell |
-2,913
| Closed | -$11.7K | – | 5806 |
|
|
2024
Q2 | $11.7K | Buy |
2,913
+719
| +33% | +$2.9K | ﹤0.01% | 5459 |
|
|
2024
Q1 | $12.9K | Buy |
+2,194
| New | +$12.9K | ﹤0.01% | 5338 |
|
|
2023
Q3 | – | Sell |
-13,668
| Closed | -$149K | – | 5700 |
|
|
2023
Q2 | $149K | Buy |
+13,668
| New | +$149K | ﹤0.01% | 4809 |
|
|
2023
Q1 | – | Sell |
-2,416
| Closed | -$24.1K | – | 6098 |
|
|
2022
Q4 | $24.1K | Sell |
2,416
-1,045
| -30% | -$10.4K | ﹤0.01% | 5319 |
|
|
2022
Q3 | $42K | Buy |
3,461
+2,594
| +299% | +$31.5K | ﹤0.01% | 5544 |
|
|
2022
Q2 | $13K | Buy |
+867
| New | +$13K | ﹤0.01% | 5466 |
|
|
2020
Q2 | – | Sell |
-1,709
| Closed | -$17K | – | 4345 |
|
|
2020
Q1 | $17K | Buy |
+1,709
| New | +$17K | ﹤0.01% | 4367 |
|
|
2019
Q4 | – | Sell |
-906
| Closed | -$8K | – | 4144 |
|
|
2019
Q3 | $8K | Sell |
906
-2,658
| -75% | -$23.5K | ﹤0.01% | 4350 |
|
|
2019
Q2 | $36K | Buy |
3,564
+2,658
| +293% | +$26.8K | ﹤0.01% | 4304 |
|
|
2019
Q1 | $15K | Buy |
+906
| New | +$15K | ﹤0.01% | 2861 |
|
|
2018
Q4 | – | Sell |
-907
| Closed | -$11K | – | 3878 |
|
|
2018
Q3 | $11K | Buy |
+907
| New | +$11K | ﹤0.01% | 3213 |
|